Ecora Resources PLC Announces Director Share Dealings in Company
LONDON, UK / ACCESS Newswire / November 18, 2025 / Ecora (LSE:ECOR)(TSX:ECOR)(OTCQX:ECRAF) (“Ecora” or the
From insight to action: TeamViewer launches Tia, the Intelligent Agent for autonomous IT support
GÖPPINGEN, Germany, Nov. 18, 2025 /PRNewswire/ — TeamViewer, a global leader in digital workplace solutions, today
HitPaw Launches 2025 Black Friday Deals: Up to 60% Off on Premium Creative Tools for a Limited Time
NEW YORK, Nov. 17, 2025 /PRNewswire/ — HitPaw, a pioneer in intuitive and powerful multimedia
Pilot Awards Empower 27 Leaders to Advance Brain Health Innovation Across 21 Countries
Projects by emerging leaders address brain health through education, creativity, and innovation worldwide. CHICAGO, Nov.
Augmented Reality Training System integrated on Apache attack helicopter platform
First-ever AR flight training system integration on rotorcraft platform demonstrates next-generation military pilot training technologies
Fujifilm Launches Bioethics Advisory Committee to Guide Ethical Decision-Making Across Life Sciences and Healthcare Businesses in the Americas
New advisory committee will uphold and strengthen Fujifilm’s commitment as a life sciences and healthcare
Epic Brings Bestselling HarperCollins Children’s Books to Its Digital Reading Platform
SAN JOSE, California, Nov. 17, 2025 /PRNewswire/ — Epic, the leading digital reading platform for
VetsinTech Honors Excellence in Veteran Support at Annual Gala
Leading Organizations Recognized for Outstanding Contributions to Veterans SAN FRANCISCO, Nov. 17, 2025 /PRNewswire/ —
Technology Empowers Platform, Value Connects Future: EPWK’s Path to an Intelligent Service Ecosystem
XIAMEN, China, Nov. 17, 2025 /PRNewswire/ — “The transaction process and fund escrow mechanism on
First Feature Film Created with OpenAI’s Sora 2: My Boyfriend Is a Superhero!?
The landmark film by filmmaker and theorist Hooroo Jackson is the first fully AI CG-animated
Accession Therapeutics doses first patient in Phase 1 clinical trial of TROCEPT-01 (ATTR-01), a novel cancer immunotherapy
OXFORD, England, Nov. 17, 2025 /PRNewswire/ — Accession Therapeutics Limited, a biopharmaceutical company developing next
iFFALCON Brings Its Art-Forward, High-Performance Smart TV to U.S. Homes
iFFALCON Launches Bezel-Less Premium Smart TV Backed by a Global TV Leader New York, NY
VITRONIC Secures Multi-Year, Multi-Million-Dollar Contract With Montgomery County, MD
A Multi-Year Agreement for Automated Traffic Enforcement Program to Support the County’s Vision Zero Initiative
Optimal Dynamics Appoints Jonathan Pollack as Chief Revenue Officer to Scale Growth Following Series C Funding
Global AI and SaaS Executive Tapped to Drive Industry Adoption of Decision Automation NEW YORK
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue
Initial results of ongoing investigator-initiated proof-of-concept trial demonstrate crofelemer can potentially extend the lives of
Matter Family Office and IWP Family Office Combine to Offer One of the Most Comprehensive Family Office Solutions for Ultra-High-Net-Worth Families
Merger Expands Capabilities While Enhancing High-Touch, Generational Service https://www.youtube.com/watch?v=x7n_c5F6y48 ST. LOUIS, MO / ACCESS Newswire
The Electrification and Decarbonization of 55 Water Street
55 Water Street’s electrification and decarbonization initiative leverages Trane Technologies’ thermal management technology to transform
XCF Global and BGN Developing Global Distribution and Logistics Partnership
Strategic partnership between XCF Global and BGN to jointly develop global distribution and logistics infrastructure
Atlas Salt to Begin Trading on OTCQX Under the Symbol “SALQF”
ST. GEORGE’S, NEWFOUNDLAND AND LABRADOR / ACCESS Newswire / November 17, 2025 / Atlas Salt
Medicus Pharma Ltd. Announces Filing of FDA Commissioner’s National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
SKNJCT-003 Doxorubicin containing Microneedle Array (D-MNA) clinical development program to non-invasively treat BCC aligns with